Announcements Trials
Browse Landscape

Status

Completed 26Recruiting 12Unknown 7Terminated 6Not yet recruiting 5Active not recruiting 4Suspended 2Enrolling by invitation 2Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 438Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 176Colorectal Neoplasms 158Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 131Lymphoma 128Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Head and Neck Neoplasms 101Brain Neoplasms 101Recurrence 100Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 75Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Renal Insufficiency, Chronic × Clear all
NCT02778295 2023-02-13

BioFabry

CENTOGENE GmbH Rostock

Withdrawn

Angiokeratoma, Fabry Disease, Hearing Loss, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡